S. 185: PATH Act


Jan 16, 2015


Reported by Committee on Apr 6, 2016

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on April 6, 2016.


Orrin Hatch

Senior Senator from Utah



Read Text »
Last Updated: Apr 18, 2016
Length: 18 pages


52% chance of being enacted (details)

About the bill

Full Title

A bill to create a limited population pathway for approval of certain antibacterial drugs.

The bill’s titles are written by its sponsor.

Read CRS Summary >


Jan 16, 2015

This is the first step in the legislative process.

Apr 6, 2016
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Passed Senate

Passed House

Signed by the President

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source


Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.


Click a format for a citation suggestion: